Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Rituxan (Rituximab) and Biosimilar market was valued at US$ 4244.4 million in 2022 and is projected to reach US$ 5345.4 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brand Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rituxan (Rituximab) and Biosimilar include Roche, Teva, Pfizer and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines.
This report aims to provide a comprehensive presentation of the global market for Rituxan (Rituximab) and Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rituxan (Rituximab) and Biosimilar. This report contains market size and forecasts of Rituxan (Rituximab) and Biosimilar in global, including the following market information:
Global Rituxan (Rituximab) and Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rituxan (Rituximab) and Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Rituxan (Rituximab) and Biosimilar companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rituxan (Rituximab) and Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rituxan (Rituximab) and Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rituxan (Rituximab) and Biosimilar Market Segment Percentages, by Type, 2022 (%)
Brand
Biosimilar
Global Rituxan (Rituximab) and Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rituxan (Rituximab) and Biosimilar Market Segment Percentages, by Application, 2022 (%)
Child
Adult
Global Rituxan (Rituximab) and Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rituxan (Rituximab) and Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rituxan (Rituximab) and Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rituxan (Rituximab) and Biosimilar revenues share in global market, 2022 (%)
Key companies Rituxan (Rituximab) and Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Rituxan (Rituximab) and Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Teva
Pfizer
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rituxan (Rituximab) and Biosimilar, market overview.
Chapter 2: Global Rituxan (Rituximab) and Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Rituxan (Rituximab) and Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rituxan (Rituximab) and Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rituxan (Rituximab) and Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Rituxan (Rituximab) and Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rituxan (Rituximab) and Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rituxan (Rituximab) and Biosimilar Overall Market Size
2.1 Global Rituxan (Rituximab) and Biosimilar Market Size: 2022 VS 2029
2.2 Global Rituxan (Rituximab) and Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rituxan (Rituximab) and Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Rituxan (Rituximab) and Biosimilar Players in Global Market
3.2 Top Global Rituxan (Rituximab) and Biosimilar Companies Ranked by Revenue
3.3 Global Rituxan (Rituximab) and Biosimilar Revenue by Companies
3.4 Global Rituxan (Rituximab) and Biosimilar Sales by Companies
3.5 Global Rituxan (Rituximab) and Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rituxan (Rituximab) and Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rituxan (Rituximab) and Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rituxan (Rituximab) and Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Rituxan (Rituximab) and Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Rituxan (Rituximab) and Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Rituxan (Rituximab) and Biosimilar Market Size Markets, 2022 & 2029
4.1.2 Brand
4.1.3 Biosimilar
4.2 By Type - Global Rituxan (Rituximab) and Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Rituxan (Rituximab) and Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Rituxan (Rituximab) and Biosimilar Revenue, 2024-2029
4.2.3 By Type - Global Rituxan (Rituximab) and Biosimilar Revenue Market Share, 2018-2029
4.3 By Type - Global Rituxan (Rituximab) and Biosimilar Sales & Forecasts
4.3.1 By Type - Global Rituxan (Rituximab) and Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Rituxan (Rituximab) and Biosimilar Sales, 2024-2029
4.3.3 By Type - Global Rituxan (Rituximab) and Biosimilar Sales Market Share, 2018-2029
4.4 By Type - Global Rituxan (Rituximab) and Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rituxan (Rituximab) and Biosimilar Market Size, 2022 & 2029
5.1.2 Child
5.1.3 Adult
5.2 By Application - Global Rituxan (Rituximab) and Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Rituxan (Rituximab) and Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Rituxan (Rituximab) and Biosimilar Revenue, 2024-2029
5.2.3 By Application - Global Rituxan (Rituximab) and Biosimilar Revenue Market Share, 2018-2029
5.3 By Application - Global Rituxan (Rituximab) and Biosimilar Sales & Forecasts
5.3.1 By Application - Global Rituxan (Rituximab) and Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Rituxan (Rituximab) and Biosimilar Sales, 2024-2029
5.3.3 By Application - Global Rituxan (Rituximab) and Biosimilar Sales Market Share, 2018-2029
5.4 By Application - Global Rituxan (Rituximab) and Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Rituxan (Rituximab) and Biosimilar Market Size, 2022 & 2029
6.2 By Region - Global Rituxan (Rituximab) and Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Rituxan (Rituximab) and Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Rituxan (Rituximab) and Biosimilar Revenue, 2024-2029
6.2.3 By Region - Global Rituxan (Rituximab) and Biosimilar Revenue Market Share, 2018-2029
6.3 By Region - Global Rituxan (Rituximab) and Biosimilar Sales & Forecasts
6.3.1 By Region - Global Rituxan (Rituximab) and Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Rituxan (Rituximab) and Biosimilar Sales, 2024-2029
6.3.3 By Region - Global Rituxan (Rituximab) and Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Rituxan (Rituximab) and Biosimilar Revenue, 2018-2029
6.4.2 By Country - North America Rituxan (Rituximab) and Biosimilar Sales, 2018-2029
6.4.3 US Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.4.4 Canada Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.4.5 Mexico Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Rituxan (Rituximab) and Biosimilar Revenue, 2018-2029
6.5.2 By Country - Europe Rituxan (Rituximab) and Biosimilar Sales, 2018-2029
6.5.3 Germany Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.5.4 France Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.5.5 U.K. Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.5.6 Italy Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.5.7 Russia Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.5.9 Benelux Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Rituxan (Rituximab) and Biosimilar Revenue, 2018-2029
6.6.2 By Region - Asia Rituxan (Rituximab) and Biosimilar Sales, 2018-2029
6.6.3 China Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.6.4 Japan Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.6.5 South Korea Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.6.7 India Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Rituxan (Rituximab) and Biosimilar Revenue, 2018-2029
6.7.2 By Country - South America Rituxan (Rituximab) and Biosimilar Sales, 2018-2029
6.7.3 Brazil Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.7.4 Argentina Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rituxan (Rituximab) and Biosimilar Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Rituxan (Rituximab) and Biosimilar Sales, 2018-2029
6.8.3 Turkey Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.8.4 Israel Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
6.8.6 UAE Rituxan (Rituximab) and Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Rituxan (Rituximab) and Biosimilar Major Product Offerings
7.1.4 Roche Rituxan (Rituximab) and Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Rituxan (Rituximab) and Biosimilar Major Product Offerings
7.2.4 Teva Rituxan (Rituximab) and Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Rituxan (Rituximab) and Biosimilar Major Product Offerings
7.3.4 Pfizer Rituxan (Rituximab) and Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Rituxan (Rituximab) and Biosimilar Major Product Offerings
7.4.4 Amgen Rituxan (Rituximab) and Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
8 Global Rituxan (Rituximab) and Biosimilar Production Capacity, Analysis
8.1 Global Rituxan (Rituximab) and Biosimilar Production Capacity, 2018-2029
8.2 Rituxan (Rituximab) and Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Rituxan (Rituximab) and Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rituxan (Rituximab) and Biosimilar Supply Chain Analysis
10.1 Rituxan (Rituximab) and Biosimilar Industry Value Chain
10.2 Rituxan (Rituximab) and Biosimilar Upstream Market
10.3 Rituxan (Rituximab) and Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rituxan (Rituximab) and Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
